PT Medco Energi Internasional Tbk Stocks

IDR 1740Last Updated 27.04.2026

Issuer Rating

5/7
Performance

Strong

Risk

Moderate

Recommendation

Hold

Market Cap

IDR 2.58B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
IDR 1740
Key Takeaways

Risk factor

Meaningful price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

PT Medco Energi Internasional Tbk, an energy and natural resources company, explores for and produces oil and gas. The company operates 11 exploration and production blocks, 1 development block, and 4 exploration blocks in Natuna, Sumatra, Kalimantan, Java, and Sulawesi in Indonesia; and holds oil and gas assets in the Vietnam, Thailand, Oman, Libya, Yemen, Malaysia, Mexico, and Tanzania. It also engages in the power business; copper and gold mining operations in Sumbawa Island, Nusa Tenggara; and operation of compression station with three gas compressors and 10 pipeline facilities in Gunung Megang, South Sumatra. The company was formerly known as PT Medco Energi Corporation and changed its name to PT Medco Energi Internasional Tbk in 2000. The company was founded in 1980 and is headquartered in Jakarta, Indonesia. PT Medco Energi Internasional Tbk is a subsidiary of PT Medco Daya Abadi Lestari.

Company Valuation

Undervalued
6/7

From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITDA, unde

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of MEDC.JK is 1722 and suggests 1% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to d

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks